FDA Announces New Initiative to Modernize the Regulation of Clinical
FDA Announces New Initiative to Modernize the Regulation of Clinical Trials and Bioresearch Monitoring
The new effort is part of an HHS-wide initiative to employ recent advances in basic science, including genomics and molecular analysis, in order to bring about more effective development and review of therapies, and to enable increasingly targeted and individualized care management for patients.